Your session is about to expire
← Back to Search
Remote Heart Failure Monitoring for Heart Failure (LINK-HF2 Trial)
LINK-HF2 Trial Summary
This trial will test whether a remote monitoring system can be used to detect worsening heart failure before the patient needs medical care, in order to change their treatment and avoid a hospitalization.
LINK-HF2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLINK-HF2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LINK-HF2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My heart condition limits my physical activity.I am willing and able to follow all study requirements.I cannot wear devices due to skin damage or severe arthritis.I have seizures or neurological issues causing abnormal movements or tremors.I am 18 years old or older.I am expected to get a heart pump or heart transplant within the next month.
- Group 1: Control
- Group 2: Active arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still slots available for participants in this trial?
"According to clinicaltrials.gov, this experiment is currently in a recruiting state and has been since April 19th 2021. The relevant information was last updated on March 23rd 2022."
What is the scope of participation for this research project?
"Affirmative. According to clinicaltrials.gov, this research is currently in search of participants, with the first post dating back to April 19th 2021 and most recent amendment on March 23rd 2022. 240 patients are sought after from 5 specified medical sites."
Are there numerous venues in the United States conducting this research?
"This research project is occurring at 5 different locations, such as the Michael E. DeBakey VA Medical Center in Houston, TX; the VA Palo Alto Health Care System in Palo Alto, CA; and the VA Salt Lake City Health Care System in SaltLakeCity, UT. Additionally, there are two other sites participating."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger